Eary Infusion of Eptinezumab for TreatmEnt of ACute Post-Traumatic Headaches (ELITE-ACT) | MicrobiomeTrials← Back to trialsNCT07191145
Eary Infusion of Eptinezumab for TreatmEnt of ACute Post-Traumatic Headaches (ELITE-ACT)
RecruitingPHASE3INTERVENTIONAL
Trial Details
Start: 2026-11Est. Completion: 2027-06-30
Enrollment target: 80 participants Locations- Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada
Other microbiome trials you might be interested in
Central Nervous System Sensitization
To investigate the use of balance as a screening tool for Central Sensitization, a condition of the nervous system that …
Marietta, United StatesCompleted Jan 2018
Mild Traumatic Brain Injury
The investigators hypothesize that patients with mild TBI and normal TCD can be safely discharged home immediately after…
Clermont-Ferrand, FranceCompleted Aug 31, 2025